- About
About
- Patients
The first patient, who was included in the clinical trial of the first domestic CAR T-cell drug “Utzhefra”, has completed the first stage of treatment without complications and switched to an outpatient regimen to evaluate the drug's long-term effectiveness.
Several years ago, the brother of Denis Larin, a Muscovite named Anton, faced a serious diagnosis of blood cancer. It was a real challenge for the whole family. To help his brother in some way, Denis became a blood donor, and a few years later, received the title of Honored Donor of Russia.
Valeria Surimova, a specialist of the Information and Analytics Division, spoke at the II International Scientific Conference “AI Technologies in Science and Education,” held at Lomonosov Moscow State University, with the report “Application of Machine Learning Methods in Hematology.”
Tatiana Tselaya, an investigator with 25 years of experience, fell ill with aplastic anemia in 2020. To save her, doctors had to resort to a “double transplant.” In her interview, Tatiana describes what difficulties she faced during treatment and why her donor became one of the main people in her life.
The leadership of the NMRC for Hematology of the Ministry of Health of the Russian Federation took part in a meeting of the Council for Cooperation in the field of healthcare of the CIS.
On a day in September, Artem Velikiy learned about his diagnosis- leukemia. This story is not only about fighting the disease, but also a story about inner courage, the support of loved ones and hope for the future.
22.11.2024Artificial Intelligence in HematologyIn the Irkutsk Regional Hospital, blood is checked using a cell analysis line.
The poster presentation, “Treatment of fungal mycosis in the Russian Federation: results and prospects from the analysis of 210 clinical cases,” authored by Candidate of Medical Sciences, Lilia Gorenkova, took the II place of honor within the poster session of the XXI Russian Conference with international participation “Malignant Lymphomas.”
The NMRC for Hematology of the Ministry of Health of the Russian Federation has received permission from the Ministry of Health of the Russian Federation to conduct clinical trials of the first domestic CAR T-cell drug for the treatment of malignant blood diseases. The drug, developed at the NMRC for Hematology, was named “Utzhefra”.
The heroine of our story is Ludmila Zheltikova. She lives with her husband in Severodonetsk. Her story is an example of fortitude and perseverance, which are integral to overcoming any obstacle.
On the 7th of November, the II annual Scientific and Practical Conference, “CAR-T Academy. Day + 1 of CAR-T Cell Therapy” will be held in Moscow.
According to the federal quota, the NMRC for Hematology of the Ministry of Health of the Russian Federation, accepted for treatment: a railway worker, a furniture manufacturer, a driver and an accountant from the new territories. These men were united not only by fraternal territories, but also by severe hemophilic arthropathy.
- Patients
